Lucy Kerr • Flavio A. Cadegiani • Fernando Baldi • et. al.,, DOI: 10.7759/cureus.21272 This article has been corrected. See Kerr L, Cadegiani F A, Baldi F, et al. (March 24, 2022) Correction: Ivermectin Prophylaxis Used for COVID-19: […]
Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease
Laurent Chouchana 1,∗, Laure-Hélène Preta 1, Mylène Tisseyre 1, et. al., PMCID: PMC7907730 PMID: 33647327 Remdesivir is a novel adenosine-like nucleotide analogue, representing the first drug approved for coronavirus disease 2019 (COVID-19), albeit an uncertain clinical relevance. In […]
🧠 Long COVID and Edema: A 2025 Clinical Overview
📚 Background and Etiology Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), affects 10–30% of individuals post-infection, with symptoms persisting beyond three months. Edema—fluid accumulation in tissues—has emerged as […]
Remember Social Distancing? It Doesn’t Really Protect You From Infections, Study Shows
By StudyFinds Analysis, Reviewed by Steve Fink During the COVID-19 pandemic, most public indoor spaces required people to stand six-feet apart for social distancing when standing in line. (Photo by Prostock-studio on […]
COVID Long-Haul Illnesses: Five Years of Recovery, Research, and Hope
Five years after the global onset of COVID-19, long-haul illnesses—collectively known as long COVID—remain a complex and evolving public health challenge. Affecting millions worldwide, long COVID is now recognized as […]
Low Vitamin D Increases Risk for Severe COVID
Low vitamin D levels might increase a person’s odds of a severe bout with COVID-19, a new study says. People with a vitamin D deficiency are 36% more likely to require […]
Cats With Deadly Coronavirus Offer Insight Into Stem Cell Therapy For Long COVID
By StudyFinds Analysis In a Nutshell DAVIS, Calif. — A breakthrough study using cats with a deadly coronavirus infection suggests that stem cell therapy could offer a promising new approach for helping […]
Long COVID clinical evaluation, research and impact on society: a global expert consensus
Andrew G. Ewing, David Joffe, Svetlana Blitshteyn, et. al. Annals of Clinical Microbiology and Antimicrobials volume 24, Article number: 27 (2025) Abstract Background Long COVID is a complex, heterogeneous syndrome affecting over four hundred million people globally. There […]
🧠 Long COVID and Sleep Disorders: Mechanisms, Brain Centers, and Therapeutic Advances (2025 Review)
Sleep disturbances have emerged as one of the most persistent and disruptive symptoms of Long COVID, affecting up to 40–76% of patients months after infection2. This article synthesizes 2025 peer-reviewed […]
🫁 Long COVID and Gas Exchange Dysfunction: Interstitial Fibrosis, Therapeutic Strategies, and Reversibility
Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), continues to affect millions globally, with shortness of breath and impaired gas exchange among its most persistent symptoms. Recent peer-reviewed studies […]